Diabetes Clinical Trials in Dallas

Showing 41-60 of 284 trials

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

NCT05761301

To evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single ascending doses of ALN-KHK and to evaluate the safety, tolerability, efficacy, PK and PD of multiple doses of KHK.

Type 2 Diabetes Mellitus (T2DM)

Alnylam Pharmaceuticals49 participantsStarted Mar 2023

Phoenix, Arizona, United States • Vista, California, United States • Lake Worth, Florida, United States +12 more locations

ENROLLING_BY_INVITATIONNA< 1 mile

Increasing Uptake of EHR-enabled Population Health Outreach Strategies to Improve Diabetes Screening

NCT05730582

The study team's central hypothesis is that the Parkland Diabetes Detection Program (PDDP) screening invitations targeted by race/ethnicity with culturally concordant messaging and tailored by glycemic risk (known PDM vs. unknown glycemic state) plus phone-based navigation of non-responders will be more effective at closing screening gaps than PDDP generic screening invitations and usual care, opportunistic screening alone.

Diabetes Mellitus, Type 2Pre Diabetes

University of Texas Southwestern Medical Center500,000 participantsStarted Mar 2024

Dallas, Texas, United States

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

Increasing Uptake of EHR-enabled Population Health Outreach Strategies to Improve Diabetes Screening

Diabetes Trials in Other Cities

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Models of Nutrition From Continuous Glucose Monitors

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

VasQ External Support for Arteriovenous Fistula

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

MIRACLE of LIFE Study

A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

Advancing Understanding of Transportation Options

C-myc Biomarker Study for Diabetic Foot Ulcers

Other Conditions in Dallas